about
Phase III, randomized, open-label study of daily imatinib mesylate 400 mg versus 800 mg in patients with newly diagnosed, previously untreated chronic myeloid leukemia in chronic phase using molecular end points: tyrosine kinase inhibitor optimizatiThe Effect of Imatinib Mesylate for Newly Diagnosed Philadelphia Chromosome-Positive, Chronic-Phase Myeloid Leukemia in Sub-Saharan African Patients: The Experience of Côte d'Ivoire.Tyrosine kinase inhibition: a therapeutic target for the management of chronic-phase chronic myeloid leukemia.Extracellular adenosine triphosphate activates calcium mobilization in human phagocytic leukocytes and neutrophil/monocyte progenitor cells.Haematology.Nilotinib is associated with a reduced incidence of BCR-ABL mutations vs imatinib in patients with newly diagnosed chronic myeloid leukemia in chronic phase.Turkish Chronic Myeloid Leukemia Study: Retrospective Sectional Analysis of CML Patients.Dendritic cell-based immunotherapy for myeloid leukemias.Potential mechanisms of disease progression and management of advanced-phase chronic myeloid leukemia.Deletion 9p23 to 9p11.1 as sole additional abnormality in a Philadelphia positive chronic myeloid leukemia in blast crisis: a rare eventMonitoring of response to therapy with imatinib mesylate in Chronic Myeloid Leukemia in chronic phase (CML-CP).Performance of Sokal and Eutos Scores for Predicting Cytogenetic and Molecular Response in Newly Diagnosed Chronic Myeloid Leukemia-Chronic Phase Patients on Imatinib.
P2860
Q30357011-8693361D-0BAD-4AB1-BB86-B3FAE1FC1989Q34123610-928FC338-2365-42C1-9D4B-BBB7DF495913Q34272962-17AAB949-1118-46AC-ACB8-15A383EF774EQ34572970-15E94BE6-23B0-46F9-8506-889094822297Q36723863-4E99DD94-D6A7-4B0E-B97F-ABB079BEE195Q37026026-0658066F-0997-4132-A3DF-AD8DFB450E0EQ37418970-E8758DC5-AABE-4880-930C-609760ACE822Q37420778-8E53BE53-5D00-40A3-89B1-8454A8E7EC77Q38139571-A7F84D91-D9C9-4890-9FA9-CC653043649CQ42413773-7136FD5A-EF02-4984-8207-3CA00FFFE2D8Q42982577-185A6CC5-4CD5-403C-88CE-88C51B485CDBQ53508619-8D26CF0E-47DF-467A-8E23-A1168384FDD5
P2860
description
1988 nî lūn-bûn
@nan
1988 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
Staging and prognosis in chronic myelogenous leukemia.
@ast
Staging and prognosis in chronic myelogenous leukemia.
@en
Staging and prognosis in chronic myelogenous leukemia.
@nl
type
label
Staging and prognosis in chronic myelogenous leukemia.
@ast
Staging and prognosis in chronic myelogenous leukemia.
@en
Staging and prognosis in chronic myelogenous leukemia.
@nl
prefLabel
Staging and prognosis in chronic myelogenous leukemia.
@ast
Staging and prognosis in chronic myelogenous leukemia.
@en
Staging and prognosis in chronic myelogenous leukemia.
@nl
P2093
P1476
Staging and prognosis in chronic myelogenous leukemia.
@en
P2093
P577
1988-01-01T00:00:00Z